» Articles » PMID: 33460435

Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology

Overview
Specialty Endocrinology
Date 2021 Jan 18
PMID 33460435
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Context: DICER1 mutations are found in multinodular goiter and differentiated thyroid carcinoma in children, and can be a manifestation of DICER1 syndrome, but the prevalence of DICER1 mutations and their significance in adult-onset thyroid nodules is unknown.

Objective: Determine (1) the prevalence of DICER1 hotspot mutations in thyroid nodules; (2) the frequency of a second DICER1 pathogenic variant in thyroid nodules with DICER1 hotspot mutations; (3) the prevalence of other thyroid cancer driver mutations in thyroid nodules with and without DICER1 hotspot mutations.

Methods: Population-based study of 14 993 consecutive fine needle aspiration biopsies of thyroid nodules evaluated by ThyroSeq v3. From 214 DICER1 hotspot-positive cases, we selected 61, matched to DICER1 hotspot-negative nodules. We performed full sequencing of all exons and exon-intron boundaries of DICER1.

Setting: Commercial and university-based laboratories in the United States and Canada.

Results: Among 14 993 thyroid nodules, 214 (1.4%) revealed a DICER1 hotspot mutation. A second pathogenic/likely pathogenic variant in DICER1 was found in 45/59 (76%) DICER1 hotspot-positive nodules studied while no other DICER1 variant was identified in the DICER1 hotspot-negative group by full DICER1 sequencing. Other alterations in thyroid-related genes were significantly more frequent in DICER1 hotspot-negative nodules (32/61) than in DICER1 hotspot--positive nodules (4/59) (P < .0001).

Conclusion: DICER1 alterations occur in a proportion of adult thyroid nodules and appear mutually exclusive with alterations in other thyroid cancer-related genes. DICER1 hotspot mutations occur with a second hit in most cases and could suggest occult DICER1 syndrome in adults with thyroid nodules.

Citing Articles

DICER1: The Argonaute Endonuclease Family Member and Its Role in Pediatric and Youth Pathology.

Sergi C, Minervini F Biology (Basel). 2025; 14(1).

PMID: 39857323 PMC: 11761906. DOI: 10.3390/biology14010093.


Distinctive role of mutations in distant metastatic thyroid cancer.

Shi C, Mu Z, Guo W, Zhang X, Sun D, Sun Y Chin J Cancer Res. 2025; 36(6):700-712.

PMID: 39802903 PMC: 11724183. DOI: 10.21147/j.issn.1000-9604.2024.06.08.


Histological clues of DICER1 mutations in thyroid nodules.

Jung C, Liu Z, Hirokawa M, Bychkov A Virchows Arch. 2024; 485(4):755-757.

PMID: 39231821 DOI: 10.1007/s00428-024-03915-4.


Atrophic changes in thyroid tumors are strong indicators of underlying DICER1 mutations: a bi-institutional genotype-phenotype correlation study.

Condello V, Roberts J, Stenman A, Larsson C, Viswanathan K, Juhlin C Virchows Arch. 2024; 485(1):105-114.

PMID: 38637342 PMC: 11271315. DOI: 10.1007/s00428-024-03802-y.


Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer.

Mu Z, Zhang X, Liang D, Fang J, Chen G, Guo W Chin J Cancer Res. 2024; 36(1):25-35.

PMID: 38455372 PMC: 10915639. DOI: 10.21147/j.issn.1000-9604.2024.01.03.